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The Chediak-Higashi Syndrome: Spectrum of Giant Organelles
in Peripheral Blood Cells
James G. White, M D * and C. C. Clawson, M D '

The presence of giant organelles in the cytoplasm of peripheral blood elements is diagnostic for the ChediakHigashi syndrome. These abnormal cytoplasmic inclusions
are found within neutrophils, eosinophils, basophils, lymphocytes, monocytes, and platelets. Their fine structural
characteristics differ. Neutrophils demonstrate striking variability in the size, shape, and internal features of their giant

organelles. Lymphocytes contain two different types ofgiant
inclusions, one with a smoothly homogeneous substructure,
the other with structures resembling microtubules. Emphasizing the ultrastructural similarities and differences ofthese
anomalous granulations may provide valuable clues for
understanding the basic defect of this inherited disorder.

Introduction

t r o p h i l precursors in bone marrow from patients and
animal models suggested that azurophilic lysosomes developing in promyelocytes undergo fusion during maturation to form the giant inclusions observed in peripheral
blood cells (10,11,15,17,23-29). Consequently, various investigators concluded that the process of fusion was exclusively concerned with the azurophilic organelles in the
promyelocytes and myelocytes, that itwas complete before
the cells entered the peripheral blood, and that the nonlysosomal organelles, called specific or secondary granules, were not involved in the evolution of giant organelles
(17,18,25,26,28). This view of giant CHS inclusions has
been used to explain the development of giant granules in
other CHS leukocytes, tissue cells, and organs of the body.

D e s p i t e the extreme rarity of patients with the ChediakHigashi syndrome (CHS), this disorder has attracted intense
interest since it was initially described (1-4). Pigmentary
dilution resulting in pseudo-albinism, an increased susceptibility to pyogenic infections, an accelerated phase characterized by lymphadenopathy, heptosplenomegaly, pancytopenia, and a terminal process resembling a lymphoreticular malignancy (5,6) represent its typical clinical features. Most patients die in early childhood from infection,
complications of the accelerated phase, or from the unusual lymphoreticular malignancy (7).
Giant organelles, present in the cytoplasm of most peripheral blood cells, are diagnostic of CHS. The massive
leukocyte inclusions have been particularly intriguing.
They have been subjected to many biochemical, histochemical, cytochemical, and immunochemical procedures
and explored in detail by light, phase contrast, and electron
microscopy in attempts to define their nature, origin, and
role in the disease (8-22). Because the patients are prone to
bacterial infection, most studies have focused on the polymorphonuclear leukocyte (PMN). Investigations of neu-

However, early studies in our laboratory did not agree with
this prevailing concept (11,12). Although azurophilic granules were involved in the formation ofthe large inclusions,
the process was not complete in the bone marrow. Rather,
fusion between giant organelles and normal-sized granules
c o n t i n u e d in the mature P M N , and nonlysosomal organelles as well as azurophilic lysosomes were involved. In
addition, we demonstrated other manifestations of the disease in CHS leukocytes, including a process resembling
cytoplasmic sequestration (12). Recent immunochemical
studies have confirmed and extended our early findings by
demonstrating that markers for both primary azurophilic
lysosomes and specific secondary granules are present in
the giant CHS inclusions (30).
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As a result of these studies (11,12,31), it is clear that the
prevailing concept of giant granule formation in CHS neutrophils needs to be modified. Furthermore, based on our
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recent investigations, the use of this concept to explain the
development of giant granules in other blood cells, tissues,
and organs in patients with CHS is no longer tenable. The
purpose of this report is to demonstrate that in each type of
blood cell there are unique features of giant granule formation that do not conform to the prevailing concept.

Preparation of samples for cytochemistry and electron
microscopy
The basic procedure we developed for fixation of blood
cells initially requires combining the leukocytes with an
equal volume of 0.1% glutaraldehyde in White's saline, pH
7.4, followed by sedimentation of the cells to a pellet and
subsequent fixation in 3% glutaraldehyde buffered in
White's saline, pH 7.4, for 30-60 minutes at 4°C. For
cytochemical studies, the second phase of fixation utilizes
0.5% glutaraldehyde and 2.5% paraformaldehyde in 0.1M
cacodylate buffer. The procedures for demonstrating acid
phosphatase (12) and myeloperoxidase (35) in leukocytes
have been described in detail in previous publications.
After initial fixation in glutaraldehyde or after incubation
for enzyme activities, the samples were post-fixed in either
1% osmic acid in Zetterquist's buffer, pH 7.3, 1% osmic
acid in 0.1M phosphate buffer, or 1% osmic acid in distilled
water containing 1.5% potassium ferrocyanide (36). All
fixed samples were dehydrated in a graded series of alcohols and embedded in Epon 812. Thin sections cut on an
ultra-microtome were either stained with lead citrate and
uranyl acetate or examined unstained if enzyme activities
were to be localized. The sections were studied in a Philips
301 electron microscope.

Materials and Methods
Patients
The present study is based on the examination of blood
samples from three patients with the characteristic clinical
and laboratory features of CHS, although two of the patients are no longer available for study. The third, a thirteenyear-old boy currently in excellent health, has been evaluated annually for the past nine years. The diagnosis of CHS
was made shortly after his birth. He developed a parotid
abscess in the newborn nursery, and blood smears revealed
cytoplasmic inclusions in his leukocytes typical of CHS.
Infections were frequent duringthe first few years of his life,
but in the past eight years they have been no more frequent
than in normal children of comparable age. He has no
signs of the accelerated phase of the disease. Giant
organelles typical of CHS have been observed in kerotinocytes, melanocytes, peripheral blood cells, and bone
marrow. His mother and father are unrelated, and his only
sibling, a sister, has no evidence of CHS. Most of our recent
studies have been carried out on blood samples from this
patient.

Results
Polymorphonuclear leukocytes (PMN)
Thin sections of well-preserved CHS neutrophils reveal a
striking variability in the size, shape, and internal structure
of giant organelles in their cytoplasm (Figs. 1, 2). Some of
the enlarged bodies have rounded contours or are spindle
shaped. Their enclosing membranes are sharply demarcated, and the material inside is homogenous, often with a
periodic, linear substructure. This type of giant organelle
most closely resembles the azurophilic granule, or primary
lysosome, ofthe mature normal PMN and its bone marrow
precursors. W h e n viewed in the light microscope on
Wright-stained blood smears, this form is sharply demarcated, usually spherical in shape, and stains a darker
purple color than other large masses in the CHS neutrophil.
It is reasonably well established that this type of massive
inclusion arises through fusion of smaller, perhaps normalsized, primary lysosomes during maturation of CHS neutrophils in the bone marrow (Fig. 3).

Preparation of white blood cell samples
Several different procedures have been used to collect
leukocytes from patients with CHS. In early studies we
depended on buffy coat samples of whole blood collected
in a ratio of 9:1 with 3.8% tri-sodium citrate anticoagulant
and sedimented at room temperature under a force of 200
x g (11,12). Subsequently, we have separated CHS leukocytes from w h o l e b l o o d , w h i c h was collected in
heparinized syringes, by dextran sedimentation and by a
sequential procedure involving dextran sedimentation, isolation on ficoll-hypaque density gradients, and subsequent
washing and resuspension in Hanks' balanced salt solution
(31,32). All methods have yielded excellent white cell
preparations, but each is employed to provide samples
enriched in a particular cell type. Buffy coats and samples
obtained by dextran sedimentation yield all varieties of
leukocytes and platelets. Ficoll-hypaque provides samples
rich in lymphocytes, monocytes, platelets, and basophils,
while the combination of dextran sedimentation and ficollhypaque isolation provides nearly pure samples of granulocytes (33).

Asecond variety of giant organelle is usually largerthan the
first, very irregular in surface contour, and highly variable
in the organization, structure, and electron density of its
internal content (Figs. 1, 2). This type is encountered more
freqently in mature CHS neutrophils than the first variety
and appears to occupy larger volumes of the cell
cytoplasm. These giant inclusions correspond to the irregu-
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Fig. 1. PMN from a patient w i t h CHS
Cell is irregular in form w i t h a few short pseudopods evident on its
surface. A large number of organelles occupy the cytoplasm, but only a
single lobe of the nucleus (N) is evident. Dark particles of glycogen (Gly)
are spread evenly throughout the cell and a single multivesicular body
(MVB) is apparent. Normal-sized specific or secondary granules (SG) are
dispersed throughout the cytoplasm. Three types of giant CHS organelles
are evident: 1) sharply defined borders; generally round or spindleshaped; it closely resembles azurophilic granules in promyelocytes and
myelocytes; 2) irregular in f o r m ; electron density varies considerably;
some appear swollen or in stages of degeneration, while others are intact;
3) double-ringed organelle in which cytoplasmic constituents are sequestered (X19,500).

Fig. 2. CHS neutrophil
Several lobes of the nucleus (N) are evident. Giant granules of the first
type (1) are apparent in this and an adjacent cell. The second variety (2) is
present in t w o forms, intact and diluted. Sites where fusion (F) appears to
be occurring between small granules (SG) and the massive inclusions can
be identified around the irregular borders of both giant organelles
(XI 7,000).

but can still be observed in well-preserved cells after
glutaraldehyde-osmium fixation.
Although the variable content and substructural organization ofthis form ofgiant organelle has attracted a great deal
of attention, the tortuous border is the most interesting
feature o f t h e inclusion. Careful examination of enclosing
membranes reveals multiple sites of interaction with normal-sized organelles in the surrounding cytoplasm. In
some areas, the membrane of an adjacent organelle,
whether a primary or secondary granule, fuses with the
surface of the giant body. In a few zones, an entire small
organelle appears to have been incorporated. Nucleoids
from the smaller organelles are dense and contribute to the
opaque areas after fusion. Membranous residues in the
large, irregular organelles may come from the nucleoids of
small organelles but may also derive from surfaces of
normal-sized granules.

lar, gray-blue structures present in the cytoplasm of CHS
neutrophils viewed in the light microscope. In thin section,
the internal matrix of the giant bodies displays a range of
appearances. At one end of the spectrum the basic substance is similar to the matrix material of the first form of
massive particle and may include areas in which a periodic
linear substructure can be defined. For the most part,
however, the matrix is mottled with zones of differing
density which often surround masses of ill-defined membranous residues. On occasion the membrane residues are
in parallel alignment, producing the appearance of myelin
configurations. Previous studies have shown that these
giant inclusions are unusually permeable to vital dyes (11).
Increased permeability could permit water to leak into the
massive bodies before or during fixation, resulting in a
swollen appearance and separation of the contents present
in some inclusions. The similarity of some of the enlarged
structures to bags of degenerating debris was far more
common when osmic acid was used as the only fixative (11)

When it was first proposed that giant granules continue to
fuse with small organelles, even in mature PMN, and that
secondary granules as well as azurophilic lysosomes (11,12)
were incorporated, considerable controversy resulted (37).
Yet, even a cursory examination of well-preserved CHS
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within double rings of membrane react for both acid phosphatase and myeloperoxidase. We have previously described stages in the degradation of cytoplasmic
constituents enclosed by the double ring confining lysosomal enzymes (12), and the precise relationship of these
areas of cytoplasmic sequestration to the two major giant
inclusions will be the subject of a separate report.
It is surprising that PMN from patients with CHS filled with
several varieties of giant lysosomes appear to survive normally once they reach the peripheral circulation, since
patients usually have a neutropenia attributed to destruction of maturing precursors in the bone marrow or a
mechanical inability to leave it (22,38). Nevertheless, one
might question whether the cells survive normally because
frequently we have found what appear to be dead or dying
PMN in peripheral blood samples (Fig. 4). The dead cells
have rounded contours, subsurface membrane vesiculation, condensed nuclei and cytoplasm, and sequestered
masses of glycogen. We have never encountered such cells
in the blood of normal individuals or of patients with other
blood diseases.
Fig. 3. CHS neutrophil reacted for peroxidase
Nuclear lobes (N), specific granules (SG), and glycogen particles are
distributed throughout the cytoplasm. Dense reaction product specific for
peroxidase is confined to massive organelles as well as small azurophilic
granules (AG). Some peroxidase positive organelles have smooth surface
contours, while most are irregular. The possibility that fusion continues
between large and small organelles in peripheral CHS neutrophils is
strongly suggested (XI 7,000).

Eosinophils
Eosinophils on peripheral blood smears of patients with
CHS are characteristic of the disease and confirm the
diagnosis (Fig. 5). While giant granules are always present
in CHS eosinophils and occur in no other human disease,
little attention has been paid to their development. It is
reasonably clear that the giant eosinophil granules develop
by fusion of smaller organelles (Fig. 6). Normal eosinophil
granules contain a single crystalloid in their substructure,
but the enlarged granules usually contain several of the
typical crystalloids. The larger they are, the more crystals
they may contain. Yet, among the massive inclusions in
CHS eosinophils are smaller granules similar in size and
appearance to those in normal cells. The cells vary considerably in the balance between very large inclusions and
more normal-sized granules, but the CHS eosinophils with
large inclusions have fewer individual storage granules
than those with generally smaller organelles (Fig. 7). It
seems reasonable that the larger organelles evolve at the
expense of the smaller and that the fusion process continues in mature cells.

peripheral blood cells in thin section reveals that this
concept is reasonable. The granules are huge, often with
five or more giant inclusions in the plane of sectioned
cytoplasm in a single cell. Also, all CHS neutrophils appear to contain several of the massive bodies. Considering
the sheer mass of material in the giant inclusions and the
large volume of cytoplasm they occupy, it would be virtually impossible for them to represent the normal amount
of azurophilic granule substance produced during maturation of P M N . However, the concept that the giant
organelles interacted with both primary and secondary
granules in mature CHS neutrophils has failed to gain
acceptance until recently. Rausch, et al have recently demonstrated by employing fluorescent tagged antibodies specific for c o m p o n e n t s of either primary lysosomes or
secondary granules, but not both, that the giant organelles
of CHS neutrophils contain both azurophilic and specific
granule markers (30). Their findings corroborate previous
ultrastructural studies which lacked a specific marker for
secondary granules.

In contrast to the P M N , there is little evidence of
cytoplasmic injury in CHS eosinophils. Irregular, giant
inclusions similar to the second variety observed in every
neutrophil are rarely evident. It is surprising thatthey ever
occur in eosinophils, which lack secondary granules of the
type found in PMN, but their rarity offers further support for
the concept that secondary granules are involved in forming giant inclusions in PMN.

The third variety of aberrant inclusion in PMN resembles
an autophagic vacuole. Cytoplasmic contents enclosed
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Fig. 4. CHS neutrophil
This type of cell is rare in peripheral blood of patients w i t h CHS but more
frequent in patient samples than in normal blood. It has no pseudopods
and is nearly spherical. Vesiculation is apparent just under the surface
membrane. Nuclear (N) lobes and the entire cytoplasm appear condensed. PMN of this type do not appear to be functional and may be in an
advanced stage of cell death (X25,000).

Fig. 6. CHS eosinophil reacted for peroxidase
Huge organelles containing several crystalloids as well as normal-sized
granules w i t h dense reaction product are apparent (XI7,700).

Fig. 7. CHS eosinophil
This cell contains one giant granule (GG) almost as large as a nuclear lobe
(N). Small granules are also apparent in the cytoplasm (X19,000).

Fig. 5. CHS eosinophil
Nucleus (N) is eccentric. Cytoplasm contains organelles ranging from
normal sized to huge; large organelles may contain a single crystal (C) or
many crystalloids (X18,200).
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Occasional giant granules in CHS eosinophils are poorly
preserved in thin sections. The apparent swelling and
dissolution of internal contents may be a fixation artifact.
However, since it has been shown that the massive inclusions are more permeable to vital dyes (11,39), this defect
may result in the swollen appearance which resembles the
changes observed in some of the massive inclusions of
PMN. Despite this, right-shaped, double membrane-enclosed areas resembling autophagic vacuoles, which are
common in CHS neutrophils, have rarely been observed in
eosinophils from CHS patients.
Basophils
All CHS basophils examined in thin sections have contained massively enlarged organelles (Figs. 8, 9). It is
possible that they contain an admixture of giant and more
normal-sized granules, but too few have been observed to
permit such a conclusion. Many giant basophil inclusions
appear to be massively enlarged granules of the type seen
in normal cells. Others seem swollen, as if they had taken
up water before or during fixation, and their contents
appear diluted. The resemblance of the swollen giant
inclusions to similarly altered massive granules in
eosinophils and PMN is striking and suggests that huge
organelles in the circulating granulocytes may be subject to mechanical injury in vivo or may be damaged
during separation of the cells in vitro. Giant granules of
CHS basophils often contain small crystalline inclusions
which are most easily recognized in the swollen organelles
but can also be observed in giant granules with intact
structure. Crystals of the type found in CHS basophil
inclusions do not appear in normal basophil granules and
may develop in the giant organelles after fusion has occurred. Their origin is unknown. In some giant basophil
granules the crystalline structures are quite large, resembling the multiplex crystals ofthe huge eosinophil granules.

Fig 8. CHS basophil
Several giant granules surround the nucleus (N); one appears swollen but
retains a crystalloid element (C) (XI7,000).

Lymphocytes
Giant granules are found in about 40% of CHS lymphocytes
in thin sections, which agrees well with the 50-90% found
by light microscopy. Two major types of giant inclusion
are present in the cytoplasm of CHS lymphocytes. One
appears to be smoothly homogenous in substructure or to
contain t w o or more zones of d i f f e r i n g c o m p o s i t i o n
(Fig. 10). Droplets resembling lipid and very dense deposits
associated with them are often present, suggesting the
appearance of ceroid or lipofuchsin. Lipid droplets and
dense material may be surrounded by a matrix of protein or
be complexed to a large organelle within the same enclosing
membrane. Cytochemical studies (11) have shown that this
type of organelle is acid phosphatase positive (Fig. 11).
Reaction product of acid phosphatase may fill the matrix or
be deposited only in a peripheral ring or on one side of the

Fig. 9. CHS basophil
Crystalline (C) structures are evident in several giant granules (X15,500).
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Fig. 10. CHS lymphocyte
Giant granule (GG) is clearly larger than multivesicular body (MVB) in the
cytoplasm. The huge inclusion contains a dense core and less dense
material around the periphery (X19,000).

Fig. 12. CHS lymphocyte
Giant organelle in the cytoplasm of this cell contains large numbers of
circular profiles resembling microtubules and is referred to as a tubular
inclusion (Tl) (X22,000).

11
Fig. 11. CHS lymphocyte reacted for acid phosphatase activity
Dense reaction product is local ized to a rim around the unreactive core of
the giant granule (GG) (X27,000).

Fig. 13. CHS lymphocyte
Giant tubular inclusion shown here contains innumerable circular profiles
resembling microtubules (X49,500).
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massive inclusion. The distribution of reaction product
suggests that the giant organelles have developed by fusion
and that lysosomal enzymes may be sequestered as a result.

mice with CHS, the literature suggests that enlarged lysosomes appear frequently (23, 24, 27, 28). Insofar as the
monocyte is concerned, the human disease does not appear
to conform with the animal models of CHS.

The second variety of giant inclusion (Fig. 12) is filled with
structures resembling microtubules (34). Although small
organelles containing tubules are also present in about 5%
of normal lymphocytes, they reach massive proportions in
CHS lymphocytes (Fig. 13). Normal cells may have five or
six of the tubule-filled organelles, whereas CHS lymphocytes usually reveal only one or two. The mechanism
involved in their evolution is still being evaluated. In our
original study they appeared to arise from thecytoplasm and
to be sequestered within membranes, i.e., the groups of
tubules formed first and were then surrounded by a membrane. This finding was supported by the observation that
small granules and cytoplasmic debris were often enclosed
by the same membrane as the tubular elements. Although
the tubular elements themselves were cytochemically inert,
they were occasionally surrounded by a ring of acid phosphatase (34). Either the enzyme was enclosed with masses of
tubules at the time the surrounding membrane developed,
or granules subsequently fused with the tubules to form
secondary lysosomes. While the latter possibility seemed
more likely, the initial mechanism whereby giant tubular
inclusions develop did not appear to involve fusion of
smaller organelles. Rather, the masses of tubular material
developed in the cell cytoplasm before enclosure. If this
suggested mechanism proves to be accurate, then fusion
may not be the only process whereby giant granules can
evolve, even though they may continue to expand by fusion
with lysosomal organelles after initial formation.

Nevertheless, there is some evidence that human CHS
monocytes may be involved in the disease process. In thin
sections, over 30% of the cells do have manifestations
of the disorder. However, the nature of the changes differs
significantly from those observed in granulocytes and lymphocytes. Instead of forming massive inclusions of fused
granules typical of those observed in PMN and eosinophils,
the monocyte develops, almost exclusively, the doubleringed organelles discussed above as the third form of
inclusion occurring in PMN (Figs. 14, 15). The steps in
formation of the ring-like structures were described in detail
in an earlier publication (12) and will be discussed in a later
report. The central space of the double-ringed organelle is
not empty, and, in many examples, it forms a complete
sphere enclosing a few granules or other constituents.
Cytochemical studies demonstrated that the substance between the inner and outer membranes reacts for both acid
phosphatase and myeloperoxidase. In other examples,
small granules and other cytoplasmic contents trapped
inside the double ring also stain for the two enzymes and
undergo degenerative changes. Thus, the major alteration in
CHS monocytes is the development of areas of cytoplasmic
sequestration rather than formation of giant organelles
consisting of fused granules. While the light microscope
might show the structures as giant masses of fused granular
material, the electron microscope demonstrates that they
form in a very different manner from most massive inclusions in CHS neutrophils, eosinophils, and lymphocytes.
Yet, double-ringed lysosomes also form in neutrophils and
lymphocytes and thus are not unique to CHS monocytes.
However, because they are the major aberration in monocytes from CHS patients, their formation deserves further
study.

Monocytes
Monocytes from the peripheral blood of patients with CHS
represent an enigma. The few investigators who have recorded the frequency of enlarged granules indicate that less
than 10% ofthe cells contain giant inclusions (40-43). Their
size is not very impressive, ranging from areas with four or
five azurophilic granules close together to single inclusions
0.1 to 4.6 fj. in diameter. Particles 0.1 /x in diameter cannot
be distinguished from granules in normal monocytes, and
cells with bigger inclusions may actually be large CHS
lymphocytes containing giant granules mistaken for monocytes. In our experience, giant organelles ofthe types found
in granulocytes or lymphocytes are extremely rare in monocytes from human patients with CHS. Yet, recent publications (30) would indicate that CHS monocytes are
commonly involved in the disease process and often contain
giant organelles. Studies in animal models of the human
disease indicate that 10% ofthe monocytes in mink and 28%
in cattle with CHS have abnormal granules (44). Although
precise figures have not been provided forthe monocytes of

Plasma cells
Although plasma cells are rare in peripheral blood from
patients with CHS, they occur more commonly than in
normal blood samples (Fig. 16). Giant organelles, though
infrequent, have been observed previously in CHS plasma
cells (14). Their most striking feature is the peculiar arrangement of their endoplasmic reticulum, which often resembles cells in stages of Russell body formation (45). The
tortuous arrangements observed are not seen in normal
plasma cells, and their relationship to the disease is
unknown.
Platelets
Platelets from patients with CHS have been virtually ignored
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Fig. 14. CHS monocyte
CHS monocytes are comparable in structure to normal monocytes. The
only manifestations of CHS are double-ringed organelles ( ] ) containing
granules and other cytoplasmic constituents (X16,000).

Fig. 16. CHS plasma cell
Rough endoplasmic reticulum (ER) filling the cytoplasm of the cell has a
racemous pattern not evident in normal plasma cells (X22,500).

Fig. 15. CHS monocyte
This example contains two unusual double-ringed organelles ( t ) sequestering cytoplasmic constituents (XI 5,500).

Fig. 17. CHS platelet
Giant granule (GG) in the cytoplasm of this example is very unusual.
Organelles of this type have not been observed in normal platelets or in
cells from patients w i t h other inherited platelet disorders (X50,000).
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in morphological studies, since it had been assumed that
they do not exhibit the giant granule anomaly. The impetus
for their closer examination came from recent studies
suggesting that CHS platelets are very deficient in the storage
pool of adenine nucleotides and serotonin confined to a
specialized organelle in the cell referred to as the dense
body (46,48). In the course of reevaluating CHS platelets
for this deficiency, we found (Fig. 17) that rare platelets do
contain giant organelles (49). By careful search of peripheral blood smears in the light microscope, we have also
been able to identify giant organelles in platelets, but they
occur so infrequently it is doubtful they influence platelet
function. Still, their presence in platelets indicates that the
basic CHS defect exists in this cell line and may influence
hemostatic function. Precisely how the basic pathologic
process results in platelet storage pool disease remainsto be
determined.

to areas of PMN cytoplasm apart from the huge inclusions,
resulting in the development of zones of cytoplasmic sequestration (12). The multiple defects present in CHS neutrophils may all contribute to defective function ofthe cells
and to their early demise.
It was both logical and fortuitous that the concept of giant
granules arising solely by fusion of azurophilic lysosomes
in bone marrow precursors could be extended to explain
massive inclusions in eosinophils: logical because the
eosinophil and PMN are similar in many respects and arise
from the same stem cell in bone marrow; fortuitous because the eosinophil in humans is reputed to have only a
single type of storage organelle containing a distinctive
crystalloid. Electron microscopic studies demonstrated that
giant granules of CHS eosinophils appeared to develop by
fusion of smaller azurophilic lysosomes in promyelocytes
and myelocytes, a process supported by finding multiple
crystalloid inclusions in the massive inclusions. However,
even for the eosinophil, the concept may be simplistic. In
many eosinophils, growth ofthe giantorganelles continues
in mature cells, and some of them show signs of internal
disintergration. Normal-sized azurophilic granules are present among the massive inclusions, and rare areas of the
cytoplasm reveal changes suggestive ofthe second form of
giant, irregular granule observed in PMN. The rarity ofthe
latter form in CHS eosinophils and its high frequency in
CHS neutrophils should have suggested a significant difference in processes leading to giant granule formation in
the two types of granulocytes. Apparently it did not, and, as
a result, the concept of azurophil granule fusion in bone
marrow precursor cells is still regarded by many as the only
mechanism of giant granule formation in CHS peripheral
blood PMN, eosinophils, and other leukocytes.

Discussion
The characteristic giant granulations found in nearly all
types of leukocytes in the peripheral blood of CHS patients
have fascinated investigators since the disease was first
described (1-4). Of the more than two hundred publications
devoted to the disorder, most have focused on the blood cell
defect, with emphasis on giant granules in PMN. The
emphasis is well placed, for a major problem of children
with CHS is their susceptibility to infection, and neutrophil
dysfunction may play a principal role in failure of patient
host defense (7).
However, the preoccupation with giant PMN granules may
have obscured important details ofthe pathologic process.
The many studiesof CHS neutrophils and their bone marrow
precursors have resulted in the concept that the massive
inclusions arise by fusion of small azurophilic granules in
promyelocytes and myelocytes, a process believed to be
complete by the time the cell reaches the peripheral circulation (17,18,25,26). Observations on the mechanism of
giant granule formation in PMN have been employed
without qualification to explain the formation of massive
inclusions in other blood cells, tissues, and organs of
patients with CHS.

Many workers appear to have extended the same concept
to giant granules in the monocyte (28), but, as applied to
CHS granulocytes, it is not tenable. Light microscopic
studies have indicated that 10% or less of peripheral blood
monocytes from CHS patients contain giant organelles
(40-43), which consisted of four or five azurophilic granules close together in one area of the cytoplasm. Large
inclusions were described in a few CHS monocytes, but
their cells may have been large lymphocytes. Smears from
five different patients here failed to reveal any typical giant
azurophilic lysosomes in their monocytes.

The present study has demonstrated that the basic pathology of CHS is far more complex than can be deduced from
a single cell type. Even in the PMN simple fusion of
azurophilic granules cannot completely explain the origin
of massive inclusions, their effects on other organelles in
neutrophil cytoplasm, and their deleterious influence on
cell functions. We have shown (11, 12, 31) thatthe process
of granule fusion continues in the mature PMN and involves specific granules as well as azurophilic lysosomes.
Furthermore, the influence ofthe disease process extends

The CHS monocyte, however, does show manifestations of
the disease. In thin sections, more than a third reveal
various stages in the formation of double-ringed structures
enclosing areas of the cytoplasm or surrounding small
groups of azurophilic granules. In our earlier studies, we
demonstrated the sequential formation of double rings and
showed that the substance between the two rings of mem-
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brane was acid phosphatase positive. Recently, we have
shown that both this substance and the encircled granules
are peroxidase positive. While double-ringed, spherical
organelles have also been identified in CHS lymphocytes
and PMN, they are far more common in the monocyte. In
our opinion, they constitute the major manifestation of
CHS in this cell type. As shown previously, this unusual
organelle arises by fusion, but the structures involved in its
formation do not appear to be typical azurophilic granules,
even though the substance between the double-ringed
membranes stains for acid phosphatase and peroxidase,
which are constituents of the lysosomal granules of the
monocyte. Instead, the structural elements appear to develop from small, atypical granules, from segments ofthe
terminal cisternae of the Golgi zone, or from elements of a
specialized region of Golgi-associated, smooth endoplasmic reticulum, referred to as the Golgi-endoplasmicreticulum-lysosome (GERL). Although further studies will
be required to establish their precise origin, it is clear that
giant organelle formation in monocytes does not involve a
fusion process like that proposed for giant inclusions in
granulocytes.

Small granules and cytoplasmic constituents are found
occasionally within the membrane, and debris surrounding
the tubules has been observed to react for acid phosphatase. These giant tubular inclusions do not result by
fusion of azurophilic lysosomes, but by a process resembling cytoplasmic sequestration. Even though lysosomal
granules may subsequently fuse with and convert them to
secondary lysosomes, the mechanism of formation is not
consistent with the concept proposed to explain the formation ofgiant inclusions in CHS granulocytes.

Conclusion
The present study has demonstrated that the CHS anomaly
of circulating blood cells is far more complex than the
prevailing view would suggest. Although fusion of
azurophilic granules takes place in bone marrow precursors of the granulocyte series and is the major factor
contributingto the massive inclusions in CHS eosinophils,
it is not limited to interactions between azurophilic granules in precursor cells. It continues at all stages of leukocyte
development and involves secondary granules and other
cytoplasmic components, as well as azurophilic lysosomes, in mature CHS neutrophils. Striking differences in
fusion processes observed in PMN and eosinophils emphasize the importance of looking for features of the disease
unique to each cell type, as well as for aspects common to
all CHS cells.

The lymphocyte also poses a problem for the accepted
concept of fusion of azurophilic lysosomes, since about
75% of CHS lymphocytes on peripheral blood smears
contain one or two giant inclusions. Study of thin sections
of the cells has confirmed this high frequency and has also
shown that there are two types of giant inclusions in CHS
lymphocytes. The first variety is a complex organelle containing homogenous protein or constituents resembling
lipid droplets, ceroid or lipofuchsin pigment, or debris. We
have observed stages of fusion between small granules in
CHS lymphocytes that resulted in this type of large inclusion. It reacts for acid phosphatase, and the asymmetric
distribution of enzyme reaction product suggests that it
arises by fusion of smaller granules (11). The organization of
reaction product also suggests that fusion occurs between
lysosomes and nonlysosomal organelles. The second variety of giant organelle is composed of tightly packed masses
of circular profiles very similar in appearance to microtubules (34). It appears to result from masses of tubules
aggregating in an area of the cytoplasm, followed by
enclosure within a membrane. The origin ofthe microtubular material and the enclosing membrane are uncertain.

Studies of CHS monocytes and lymphocytes are also pertinent, as examination ofthe anomaly in CHS monocytes has
shown a process of producing enlarged organelles far
different from the mechanism proposed for giant inclusions
in granulocytes. When viewed in the light microscope, a
few CHS monocytes may appear to contain masses of fused
azurophilic granules, but electron microscopy reveals that
the mechanism of their formation is quite distinct from the
process of azurophilic granule fusion in PMN and
eosinophils. Lymphocytes, which manifest two varieties of
giant granule formation, are both similar to CHS granulocytes and different.
It is our hope that emphasis on the differences peculiar to
each cell type, as well as the similarities, will lead to a
solution to the basic defect of the CHS anomaly.
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